BIO vs THC · rev $2.58B vs P/E 9.3, rev $20.66B
BIO (BIO) versus Tenet Healthcare Corporation (THC) — a side-by-side from cached financials, not a winner call.
BIO (BIO) common stock.
Tenet Healthcare Corporation (THC) is a medical care facilities company listed on NYSE.
Latest reported BIO revenue for 2025-12-31 was $2.58B. Net income was $759.9M. Revenue was up 0.7% from 2024-12-31 to 2025-12-31. BIO currently screens at market cap $0.
Latest reported THC revenue for 2024-12-31 was $20.66B. Net income was $4.06B. Revenue was up 0.6% from 2023-12-31 to 2024-12-31. THC currently screens at market cap $15.38B and trailing P/E 9.3.
BIO currently screens at market cap $0. THC currently screens at market cap $15.38B and trailing P/E 9.3.
Not investment advice. Open the BIO and THC stock pages for the full models.
Not investment advice.